Number of megarounds drop 38% in first half as biotechs struggle against worsening slump
Summary by endpoints.news
1 Articles
1 Articles
All
Left
Center
Right
Number of megarounds drop 38% in first half as biotechs struggle against worsening slump
Even biotech's "haves" are struggling. The sector's fraught funding environment has been in a slump going on three years, and it's created a world of "haves and have-nots" for private drug development startups. Companies with ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium